Current and historical daily PE Ratio for Medistim ASA (
FRA:MD1
) from 2019 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Medistim ASA stock (FRA:MD1) PE ratio as of Jun 20 2024 is 32.14.
More Details
Medistim ASA (FRA:MD1) PE Ratio (TTM) Chart
Medistim ASA (FRA:MD1) PE Ratio (TTM) Historical Data
View and export this data going back to 2019. Start your Free Trial
Total 1264
- 1
- 2
- 3
- 4
- 5
- 6
- 15
Medistim ASA PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-20 | 31.6 | 2024-04-17 | 32.0 |
2024-06-19 | 31.6 | 2024-04-16 | 32.3 |
2024-06-18 | 31.8 | 2024-04-15 | 34.5 |
2024-06-17 | 31.2 | 2024-04-12 | 33.7 |
2024-06-14 | 31.9 | 2024-04-11 | 33.4 |
2024-06-13 | 31.8 | 2024-04-10 | 34.5 |
2024-06-12 | 32.2 | 2024-04-09 | 34.5 |
2024-06-11 | 32.1 | 2024-04-08 | 35.4 |
2024-06-10 | 32.2 | 2024-04-05 | 34.7 |
2024-06-07 | 31.6 | 2024-04-04 | 34.7 |
2024-06-06 | 32.5 | 2024-04-03 | 34.1 |
2024-06-05 | 33.5 | 2024-04-02 | 33.3 |
2024-06-04 | 33.5 | 2024-03-28 | 32.2 |
2024-06-03 | 36.3 | 2024-03-27 | 31.7 |
2024-05-31 | 33.0 | 2024-03-26 | 31.2 |
2024-05-30 | 34.1 | 2024-03-25 | 30.6 |
2024-05-29 | 35.1 | 2024-03-22 | 31.2 |
2024-05-28 | 34.0 | 2024-03-21 | 31.2 |
2024-05-27 | 34.6 | 2024-03-20 | 31.2 |
2024-05-24 | 33.2 | 2024-03-19 | 32.8 |
2024-05-23 | 32.8 | 2024-03-18 | 33.4 |
2024-05-22 | 32.3 | 2024-03-15 | 32.9 |
2024-05-21 | 32.4 | 2024-03-14 | 33.5 |
2024-05-20 | 31.2 | 2024-03-13 | 33.9 |
2024-05-17 | 31.3 | 2024-03-12 | 32.5 |
2024-05-16 | 31.2 | 2024-03-11 | 32.6 |
2024-05-15 | 31.5 | 2024-03-08 | 33.7 |
2024-05-14 | 30.6 | 2024-03-07 | 32.8 |
2024-05-13 | 31.1 | 2024-03-06 | 33.1 |
2024-05-10 | 30.6 | 2024-03-05 | 33.5 |
2024-05-09 | 32.4 | 2024-03-04 | 34.2 |
2024-05-08 | 31.4 | 2024-03-01 | 33.5 |
2024-05-07 | 31.0 | 2024-02-29 | 36.4 |
2024-05-06 | 31.1 | 2024-02-28 | 35.4 |
2024-05-03 | 30.6 | 2024-02-27 | 35.9 |
2024-05-02 | 31.8 | 2024-02-26 | 36.4 |
2024-04-30 | 31.1 | 2024-02-23 | 36.2 |
2024-04-29 | 31.0 | 2024-02-22 | 36.8 |
2024-04-26 | 30.1 | 2024-02-21 | 36.7 |
2024-04-25 | 30.0 | 2024-02-20 | 36.0 |
2024-04-24 | 32.2 | 2024-02-19 | 36.8 |
2024-04-23 | 30.8 | 2024-02-16 | 36.7 |
2024-04-22 | 30.5 | 2024-02-15 | 36.9 |
2024-04-19 | 30.4 | 2024-02-14 | 36.8 |
2024-04-18 | 32.1 | 2024-02-13 | 36.5 |
Medistim ASA (FRA:MD1) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Medistim ASA
ISIN : NO0010159684
Compare
Compare
Traded in other countries / regions
MEDI.NorwayMD1.GermanyMEDIO.Sweden0OCD.UK IPO Date
2019-02-07Description
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, Asia, and the Rest of the World. The firm's activity is split into three strategic operating units, Capital equipment; Lease of equipment, and Distribution and sales of third-party products.